A multidisciplinary approach to the management of adrenal incidentaloma.

Multidisciplinary approach adrenal incidentaloma adrenocortical cancer pheochromocytoma primary aldosteronism surgery

Journal

Expert review of endocrinology & metabolism
ISSN: 1744-8417
Titre abrégé: Expert Rev Endocrinol Metab
Pays: England
ID NLM: 101278293

Informations de publication

Date de publication:
07 2021
Historique:
pubmed: 10 7 2021
medline: 29 1 2022
entrez: 9 7 2021
Statut: ppublish

Résumé

An adrenal incidentaloma (AI) is an adrenal neoplasm incidentally discovered during an imaging unrelated to suspected adrenal disease. The aim of the present review is to offer practical guidance on the multidisciplinary approach of AIs.Areas covered:The prevalence of AI is high in the aging population (up to 5-8%); however, hormonally active or malignant conditions are rare. After the discovery of an AI, it is suggested to assess in parallel if the mass is potentially malignant and functionally active. The answer to the former question is mainly based on medical history (extra-adrenal malignancies, new-onset of signs or symptoms) and imaging (conventional radiology and/or nuclear medicine). The answer to the latter question is a complete endocrine evaluation of both cortical (glucocorticoids, mineralocorticoids) and medullary (catecholamines) secretion.Expert opinion:A multidisciplinary discussion is suggested for patients with adrenal disease, after the exclusion of nonfunctioning benign cortical adenoma, in order to plan a close and tailored follow-up for the suspected malignant or functioning forms. Surgery is advised for patients with malignant disease (adrenocortical cancer) or with clinically relevant secreting neoplasm (primary aldosteronism, Cushing's syndrome, and pheochromocytoma).

Identifiants

pubmed: 34240680
doi: 10.1080/17446651.2021.1948327
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

201-212

Auteurs

Giacomo Voltan (G)

Endocrinology, Department of Medicine DIMED, University of Padova, Padova, Italy.

Marco Boscaro (M)

Endocrinology, Department of Medicine DIMED, University of Padova, Padova, Italy.

Decio Armanini (D)

Endocrinology, Department of Medicine DIMED, University of Padova, Padova, Italy.

Carla Scaroni (C)

Endocrinology, Department of Medicine DIMED, University of Padova, Padova, Italy.
Endocrine Disease Unit, University-Hospital of Padova, Padova, Italy.

Filippo Ceccato (F)

Endocrinology, Department of Medicine DIMED, University of Padova, Padova, Italy.
Endocrine Disease Unit, University-Hospital of Padova, Padova, Italy.
Department of Neuroscience DNS, University of Padova, Padova, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH